LLY Eli Lilly
Healthcare · Close of 19 Nov 26
⭐ Log in to follow stocks and set price alerts (free) Log in
Financials (from SEC filings)
📅 Next earnings: 3 Feb 2027 · date estimated from last year
What changed in the latest quarter (Q3 2026)
Eli Lilly (LLY) – Q3 2026 (ended Sep 30, 2026)
- Revenue: $24.4B, up 38.6% from the same quarter a year earlier.
- Gross margin: 83.9%, slightly higher than 82.9% a year ago (operating margin was not provided).
- Net margin: 26.4%, lower than 31.7% a year ago, so profit grew more slowly than sales.
- Net income: $6.5B, up 15.5%. EPS was $7.22, up 16.3%.
- Balance sheet: cash of $4.9B versus long-term debt of $47.0B.
This is a reported quarter from the 10-Q, not a derived one. Over the last 12 months, revenue was $86.5B and net income was $27.6B.
| Quarter | Revenue | Net income | EPS | Net margin |
|---|---|---|---|---|
| Q3 2026ended 30 Sept 2026 | $24.4B+38.6% YoY | $6.5B+15.5% YoY | $7.22+16.3% YoY | 26.4% |
| Q2 2026ended 30 Jun 2026 | $23.0B+47.7% YoY | $7.1B+25.3% YoY | $7.94+26.2% YoY | 30.9% |
| Q1 2026ended 31 Mar 2026 | $19.8B+55.5% YoY | $7.4B+168.1% YoY | $8.26+169.9% YoY | 37.4% |
| Q4 2025*ended 31 Dec 2025 | $19.3B+42.5% YoY | $6.6B+50.5% YoY | $7.39+51.4% YoY | 34.4% |
| Q3 2025ended 30 Sept 2025 | $17.6B+53.9% YoY | $5.6B+475.4% YoY | $6.21+480.4% YoY | 31.7% |
| Q2 2025ended 30 Jun 2025 | $15.6B+37.6% YoY | $5.7B+90.8% YoY | $6.29+91.8% YoY | 36.4% |
YoY = vs the same quarter a year earlier · quarters follow the company's fiscal year * Q4 = full year minus the first three quarters (EPS approximate)
Balance sheet as of 2026-09-30: Cash $4.9B · Long-term debt $47.0B · Equity $40.3B
Numbers from SEC EDGAR (the company's 10-Q/10-K filings), updated daily · AI summary from the numbers only, not investment advice ·Open the 10-Q filed 2026-10-29
🏛 US Congress trades in this stock (12 months)
Reports can arrive up to 45 days after the trade and give amount ranges only. By the time you see this, the trade is old news: no inside information, not a trading signal.
| Filed | Member | Asset | Type | Amount (range) | Traded |
|---|---|---|---|---|---|
| 12 Nov 26PDF | David J. TaylorOH02 · self | LLYEli Lilly and Company Common Stock (LLY) | Sell | $1,001 - $15,000 | 3 Nov 269 days later |
| 12 Nov 26PDF | David J. TaylorOH02 · self | LLYEli Lilly and Company Common Stock (LLY) | Sell | $1,001 - $15,000 | 3 Nov 269 days later |
Today's AI analysis
The AI is analysing this stock. Refresh in a moment.
⚖️ Compare LLY with another stock
For education only, not a recommendation to buy or sell. Investing involves risk.